Posted by iforgotmypassword on February 13, 2009, at 19:19:11
In reply to Sertindole up for approval mid-year, posted by jrbecker76 on February 12, 2009, at 21:52:44
...theoretically may be a very good combination. pimavanserin is supposed to allow a lower dose of antipsychotics, but while retaining the efficacy. a lower dose may possibly eliminate cardiac worries completely, below the level of occurances in other antipyschotic drugs currently available.
also pimavanserin is a very curious drug that may become a very unique cognitive enhancer in itself. it is even an agonist at the M1 receptor. it is in phase III, so it won't be available for a while, but it may be the most interesting drug in the pipeline to seek FDA approval at the moment.
poster:iforgotmypassword
thread:879789
URL: http://www.dr-bob.org/babble/20090213/msgs/879970.html